SCHEMBL24969494

SCHEMBL24969494

COC(=O)c1ccc(OS)cn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.61
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
DYRK1A Q13627 1/20 0.45
MAPT P10636 3/20 0.42
POLB P06746 1/20 0.42
LCK P06239 1/20 0.42
GABRP O00591 2/20 0.40
GABRD O14764 2/20 0.40
GABRA1 P14867 2/20 0.40
GABRB1 P18505 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
GABRB2 P47870 2/20 0.40
GABRA4 P48169 2/20 0.40
GABRE P78334 2/20 0.40
GABRA6 Q16445 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31296544 0.85 MAPK1 (0.65) MAPK1KDM4EL3MBTL1DYRK1AMAPT
SCHEMBL1545257 0.85 MAPK1 (0.65) MAPK1KDM4EL3MBTL1DYRK1AMAPT
SCHEMBL13075575 0.82 MAPK1 (0.61) MAPK1KDM4EL3MBTL1DYRK1AMAPT
SCHEMBL31620610 0.81 MAPK1 (0.59) MAPK1KDM4EL3MBTL1DYRK1APOLB
SCHEMBL10270980 0.81 MAPK1 (0.59) MAPK1KDM4EL3MBTL1DYRK1APOLB
SCHEMBL17007009 0.79 MAPK1 (0.57) MAPK1KDM4EL3MBTL1DYRK1AMAPT
SCHEMBL165125 0.79 MAPK1 (0.57) MAPK1KDM4EL3MBTL1DYRK1AALDH1A1
SCHEMBL796465 0.79 MAPK1 (0.57) MAPK1KDM4EL3MBTL1DYRK1ALMNA
SCHEMBL13466852 0.79 MAPK1 (0.57) MAPK1KDM4EL3MBTL1DYRK1AMAPT
SCHEMBL991921 0.79 MAPK1 (0.57) MAPK1KDM4EL3MBTL1DYRK1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009785-A1 TEAD INHIBITORS AND USES THEREOF CEDILLA THERAPEUTICS, INC. (US) 2023-02-02 WO disclosed